Keyphrases
Liver-expressed Antimicrobial Peptide 2
100%
Food Intake
68%
Global Longitudinal Strain
57%
Ad Libitum Food Intake
57%
Angina Pectoris
52%
Postprandial Glucose Metabolism
51%
Layer-specific Strain
50%
Liver
46%
Ghrelin Receptor Antagonist
42%
Hormone Administration
42%
Appetite Sensations
42%
Major Adverse Cardiovascular Events
42%
Layer-specific
42%
Exogenous Hormones
42%
Liver Disease Severity
42%
Non-inferiority
42%
Renin-angiotensin System
42%
Single-photon Emission Computed Tomography (SPECT)
42%
COVID-19
42%
Healthy Individuals
42%
Secretome
42%
β-hydroxybutyrate
42%
Gene Signature
42%
Inducible Ischemia
42%
Circulating Biomarkers
42%
Cardiac Function
42%
Non-alcoholic Fatty Liver Disease (NAFLD)
42%
Signature-based
42%
Renin-angiotensin System Inhibitors
42%
Postprandial Glucose Excursion
42%
Hazard Ratio
35%
Growth Hormone Secretagogue Receptor (GHS-R)
34%
Left Ventricular Ejection Fraction
23%
Ad Libitum
22%
Meal Tolerance Test
22%
Placebo-controlled
22%
Randomized Double-blind
22%
Angiotensin Receptor Blockers
21%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
21%
Epicardial
19%
Plasma Glucose
17%
Ghrelin
17%
Coronary Angiography
16%
Mixed Meal
14%
Satiety
14%
Clinical Variables
14%
Native Liver
14%
Sampling Methods
14%
Continuous Intravenous Infusion
14%
Duke Score
14%
Medicine and Dentistry
Food Intake
85%
Hepcidin
57%
Stable Angina Pectoris
52%
Glucose Metabolism
51%
Cardiovascular Disease
42%
Ischemia
42%
COVID-19
42%
Single-Photon Emission Computed Tomography
42%
Sensation
42%
Hazard Ratio
42%
Renin-Angiotensin System Inhibitor
42%
Heart Function
42%
Ghrelin Receptor
34%
Renin Angiotensin Aldosterone System
30%
Heart Left Ventricle Ejection Fraction
26%
Test Meal
22%
Placebo
22%
Coronary Angiography
18%
Ghrelin
17%
Satiety
14%
Meal
14%
Two Dimensional Speckle Tracking Echocardiography
14%
Blood Sampling
14%
Intravenous Drug Administration
14%
Endocardium
13%
SARS Coronavirus
12%
Angiotensin Receptor Antagonist
12%
False Positive Result
9%
Proportional Hazards Model
8%
Exercise Test
8%
Acute Heart Infarction
8%
Cardiovascular System
8%
Infusion
8%
Glucose Intake
8%
Growth Hormone
8%
Ejection Fraction
8%
Prospective Cohort Study
8%
Mediator
8%
Patient Population
8%
Echocardiography
8%
Clinical Trial
6%
Acute Respiratory Distress Syndrome
6%
Medicine
6%
Diabetes
6%
Randomized Clinical Trial
6%
ACE Inhibitor
6%
